DEMO is a dynamic Greek industrial and commercial organization, specializing in the development, production and supply of pharmaceutical products. The company is the largest supplier of injectables for public hospitals in Greece, exports 80% of its annual production and is recognized as one of the official suppliers of the United Nations, UNICEF, the World Health Organization (WHO), Doctors Without Borders and the International Committee of the Red Cross. With over 3,300 circulation licenses in 86 countries worldwide, the largest factory in SE Europe and over 1,400 employees, DEMO paves the way for pharmaceutical self-sufficiency for Greece and Europe. Today, DEMO implements investments of €356 million, strengthening production and R&D, while entering the development and production of active ingredients and Biotechnology. At the same time, the company is committed to ensuring equality, diversity and inclusion in the working environment and has adopted -within this context- the Diversity Charter for Greece. DEMO moves "Always Forward" driven by its corporate philosophy of providing quality and reliable pharmaceutical products, for everyone. Learn more at www.demo.gr
DEMO SA, a leading pharmaceutical manufacturer, is seeking a High-Caliber Analytical Development Mass Spectrometry Scientist to join their growing Biotechnology Center in Athens, Greece. The role involves conducting protein analysis using mass spectrometry techniques, developing and validating methods, and contributing to both process development and regulatory documentation. The position focuses on biosimilar development, with a strong emphasis on adherence to regulations and collaboration with Quality Assurance.
DEMO is a dynamic Greek industrial and commercial organization, specializing in the development, production and supply of pharmaceutical products. The company is the largest supplier of injectables for public hospitals in Greece, exports 80% of its annual production and is recognized as one of the official suppliers of the United Nations, UNICEF, the World Health Organization (WHO), Doctors Without Borders and the International Committee of the Red Cross. With over 3,300 circulation licenses in 86 countries worldwide, the largest factory in SE Europe and over 1,400 employees, DEMO paves the way for pharmaceutical self-sufficiency for Greece and Europe. Today, DEMO implements investments of €356 million, strengthening production and R&D, while entering the development and production of active ingredients and Biotechnology. At the same time, the company is committed to ensuring equality, diversity and inclusion in the working environment and has adopted -within this context- the Diversity Charter for Greece. DEMO moves "Always Forward" driven by its corporate philosophy of providing quality and reliable pharmaceutical products, for everyone. Learn more at www.demo.gr